Linked Life Data

14521706

Source:http://linkedlifedata.com/resource/pubmed/id/14521706

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2003-10-2
pubmed:abstractText
Dermatophytosis in immunocompromised hosts is more varied and often more severe than in immunocompetent hosts. Early recognition and treatment with systemic therapy are important in human immunodeficiency virus (HIV)-positive patients in order to prevent severe infection. Potential drug resistance can occur due to chronic usage of systemic azole therapy in such patients, or the existence of atypical fungi. Although warnings have been made of possible drug interactions between certain antifungals and antiretroviral medications, only one combination has shown a clinically significant interaction. A case treated aggressively with oral terbinafine at the onset is presented.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0011-9059
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
839-43
pubmed:dateRevised
2006-10-30
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Tinea corporis in human immunodeficiency virus-positive patients: case report and assessment of oral therapy.
pubmed:affiliation
Department of Microbiology and Immunology, Medical College of Ohio, Toledo, Ohio 43623, USA. cburkhart@mco.edu
pubmed:publicationType
Journal Article, Review